LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Feb 2, 2015
Emerging Company Profile
Three's company
How the serotonin component of Neurovance's ADHD candidate could set it apart
Read More
BioCentury
|
Jun 3, 2013
Clinical News
Amitifadine: Phase IIb/IIIa data
Read More
BioCentury
|
Oct 22, 2012
Clinical News
Amitifadine: Completed Phase IIb/IIIa enrollment
Read More
BioCentury
|
Oct 22, 2012
Finance
Maximizing depression
Euthymics spins out Neurovance; clears way for potential deal in depression
Read More
BioCentury
|
Oct 19, 2012
Company News
Euthymics' Neurovance spinout raises $7M
Read More
BioCentury
|
Dec 5, 2011
Emerging Company Profile
Euthymics: Balancing act
Euthymics: Correct balance of triple reuptake inhibition will be key in MDD
Read More
Items per page:
10
1 - 6 of 6